Telling Gastroesophageal Junction Cancer Apart From Lower Esophageal Cancer

Yes. In widespread metastasis there is a possible benefit from chemotherapy combined with immunotherapy or targeted therapy. How much survival advantage this brings is, statistically, maybe a couple of months, but it will definitely improve the patient's quality of life during that period.

Essentially, whole-body axial imaging: a PET-CT if it is available, and if not, a contrast-enhanced scan covering the neck, thorax, abdomen and pelvis for staging. In addition, endoscopic ultrasound is used in early-stage disease for more accurate T and N staging, and bronchoscopy and laparoscopy may be used in locally advanced disease, laparoscopy specifically to rule out peritoneal metastasis in cases of adenocarcinoma.

Prevention starts with understanding the risk factors, which depend on the histological subtype. For adenocarcinoma, the drivers can be obesity, reflux disease, and smoking and alcohol, so limiting smoking and alcohol matters, and an existing reflux disease needs to be managed medically. Patients with an already existing condition should also be started early on more stringent endoscopic surveillance. For squamous cell carcinoma, the pathology is more related to smoking and diet habits, and regulating those can make a difference.

There is a lot of ignorance in our community, especially in our country, about a complex disease like esophageal cancer. Patients have early, subtle symptoms of difficulty swallowing, but they are often ignored and mistaken for some other common ailment. The need for awareness is foremost. As doctors, we should involve ourselves in educating more and more of the public about the disease, its diagnosis and the treatments available, so that if it is detected early, we can offer patients the maximum curative options.

That is a very valid question. Even in our community we see a lot of cases of caustic esophageal injury, and this chronic esophagitis can eventually lead to stricturous disease and become a predisposing cause for esophageal cancer. Patients who survive such an injury and go on to develop stricturous disease should be kept on a very stringent surveillance protocol.

Through endoscopic mapping, using a landmark of around 40 cm from the incisors that varies with the patient's own esophageal length.

The axial imaging representation is preferred, and the diagnosis is finalised on that basis.

Locally advanced adenocarcinoma at the GE junction extending into the proximal stomach needs a staging laparoscopy to rule out peritoneal metastasis, a step not automatically required for a purely lower-esophageal tumour.